Kevin Clarke

Kevin Clarke is an experienced executive in the pharmaceutical industry, currently serving as the Executive Director of US Market Access & Reimbursement at Alexion Pharmaceuticals, Inc. since September 2019. Prior roles include Executive Director of Strategic Accounts & Access at Intercept Pharmaceuticals, where Kevin led the Strategic Accounts team, and various positions at ThromboGenics, Acorda Therapeutics, Endo Pharmaceuticals, and Genentech, showcasing a strong background in market access, reimbursement, and commercial leadership. Kevin holds a Bachelor of Arts degree in History and Political Science from the University of Rhode Island, earned between 1988 and 1992.